뉴스벤징가
4D Molecular's One-Shot Eye Therapy Delivers Two-Year Win
· 발표
기사 요약
4D Molecular Therapeutics reports positive 2-year Phase 2b data for 4D-150 in wet AMD, showing up to an 87% cut in treatment burden.
기사 원문에서 발췌했어요.4D Molecular Therapeutics reports positive 2-year Phase 2b data for 4D-150 in wet AMD, showing up to an 87% cut in treatment burden.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…